A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to H5N1 Vaccine in Adults
Conditions: Influenza; HealthyInterventions: Biological: Multimeric 001 (M-001); Biological: H5N1 influenza vaccine; Biological: SalineSponsors: BiondVax Pharmaceuticals ltd.; Seventh Framework ProgrammeRecruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2016 Category: Research Source Type: clinical trials